Articles from Warning Letter Bulletin (July 1, 2006)

Title	Author	Type	Words
Agency seeks to have clincial investigator disqualified from further studies.			397
Aksys, Ltd, Lincolnshire, IL, June 8 (CDRH).			133
Cell Point, Centennial, CO, June 12 (CDER).			358
Dux Industries, Oxnard, CA, June 1 (Los Angeles).			326
Electric Mobility Corp., Sewell, NJ, June 1 (New Jersey).			277
Envita Natural Medical Centers of America, Scottsdale, AZ, June 14 (CBER).			391
Gaymar Industries, Orchard Park, NY, June 8 (New York).			307
GlaxoSmithKline, Research Triangle Park, NC, June 30 (DDMAC).			558
Guilin Pharmaceutical Corp., Guilin Guangxi, China, June 23 (CMV).			295
International BioResources, LLC, LaFayette, LA, June 22 (Dallas).			325
Massimo Cristofanilli, M.D., MD Anderson Cancer Center, Houston, June 16 (CDER).			431
MD Anderson Cancer Center, Houston, June 15 (CDER).			646
PrimaPharm, San Diego, June 29 (DDMAC).			238
Ranbaxy Labs, Paonta Sahib, India, June 15 (CDER).			496
Sanofi Pasteur, Inc., Swiftwater, PA, June 30 (ORA/OE).			358
Scott A. Spiro, M.D., West Orange, NJ, June 28 (CDRH).			761
The Power Mall, Versailles, MO, June 28 (Kansas City).			279
Tri-State Hospital Supply Corp., Howell, MI, June 2 (Detroit).			456
Vail Valley Medical Center IRB, Vail, CO, June 22 (CDRH).			462
Vapotherm, Inc., Stevensville, MD, June 12 (Baltimore).			476
Visionary Contact Lens, Anaheim, CA, June 1 (Los Angeles).			348
Watson Laboratories Caribe, Inc., Corona, CA, June 19 (San Juan).			318